Article

Clinical Trials: An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis

This clinical trial will determine if AL-46383A ophthalmic solution is an effective treatment for adenoviral conjunctivitis.

Study Type: Interventional

Age/Gender Requirements: 6 years+ (male/female)

Sponsor: Alcon Research

Purpose: To determine the safety and efficacy of AL-46383A Ophthalmic Solution in the treatment of adenoviral conjunctivitis.

Click here to access this third-party resource.

Related Videos
FDA News Month in Review: September 2024
HCPLive Five at Maui Derm NP+PA Fall 2024 | Image Credit: HCPLive
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
Steve Nissen, MD | Credit: Cleveland Clinic
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
Sherona Bau, NP | Credit: UCLA Health
© 2024 MJH Life Sciences

All rights reserved.